Organophosphate Poisoning: Clinical Trials

14 trials for Organophosphate Poisoning, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 unknown, 1 recruiting, 1 terminated. 7 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 4, Unknown 2, Recruiting 1
Phase 23Completed 2, Withdrawn 1
Phase 33Completed 2, Withdrawn 1
Phase 12Completed 1, Terminated 1
Phase 41Completed 1

Follow Organophosphate Poisoning: new trials by email Literature Review of Organophosphate Poisoning trials Research Report on Organophosphate Poisoning

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Magnesium Sulphate With Atropine and Pralidoxime vs Standard Therapy Alone in Acute Organophosphate Poisoning
Atropine plus pralidoxime, Atropine and pralidoxime with adjunctive MgSO4 - Organophosphate Poisoning
Not applicableRecruitingMuhammad Aamir Latif382026-05-102026-08-20
Fresh Frozen Plasma Transfusion in Acute Organophosphate Poisoning
fresh frozen plasma - Organophosphorus Poisoning
Not applicableUnknownAin Shams University922024-08-012024-02-13
Role of Intralipid in Management of Organophosphorus Poisoning
Intralipid, 20% Intravenous Emulsion, Intravenous Atropine Sulfate - Organophosphorus Poisoning
Phase 2 / Phase 3WithdrawnAmani Hassan Abdel-Wahab2024-04-012025-10-03
Paraoxonase-1 Pseudo Cholinesterase Organophosphate Toxicity Enzyme in Prediction the Severity and Outcome of Acute Organophosphate Poisoning and Its Correlation With Pseudo Cholinesterase Enzyme Level.
Serum Pararoxonase -1 level, Diagnostic Test: Serum pseudocholinesterase enzyme level - Organophosphate Poisoning
Not applicableUnknownSohag University902024-01-012023-10-31
Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime
Pralidoxime, Atropine - Organophosphorus Poisoning
Phase 2CompletedSir Salimullah Medical College Mitford Hospital962022-06-012024-10-09
A Study to Evaluate the Intramuscular Administration of Scopolamine
Scopolamine Hydrobromide Trihydrate - Medical Countermeasures, Organophosphate Poisoning
Phase 1TerminatedBattelle Memorial Institute322020-06-022025-02-19
To Study the Effects of Lipid Emulsion on Hemodynamics in Organophosphate Compound Poisoning
Lipid Emulsion - Organophosphate Poisoning
Phase 4CompletedPost Graduate Institute of Medical Education and Research, Chandigarh402015-09-012018-06-21
Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning
Standard care, Standard care+ 2.5 mg Salbutamol, Standard care+ 5 mg Salbutamol - Organophosphate Poisoning
Phase 3CompletedSylhet M.A.G.Osmani Medical College752015-04-012015-12-29
The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers
Organophosphate, Placebo - Organophosphate Poisoning
Not applicableCompletedBispebjerg Hospital422014-09-012023-07-28
Farming, Personal Protective Equipment, Nepal
LAPPE (locally adapted personal protective equipment) - Organophosphate Poisoning
Not applicableCompletedBispebjerg Hospital452014-08-012015-02-23
A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning
Rocuronium, Sugammadex - Organophosphate Poisoning
Phase 2 / Phase 3CompletedUniversity of Edinburgh452014-05-012016-11-17
A Study of Inhaled Atropine Sulfate in Healthy Adults
atropine sulfate - Organophosphorus Poisoning
Phase 1CompletedMicroDose Defense Products L.L.C.182009-08-012010-08-12
A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers
Rivastigmine - Rivastigmine Toxicity
Not applicableCompletedTel-Aviv Sourasky Medical Center152009-01-012014-03-27
Study to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.
Pralidoxime(drug) - Acute Organophosphorus Pesticide Poisoning
Not applicableCompletedGiriraj Hospital2002000-05-012006-06-06

Broader conditions

Chemically-Induced Disorders (14)  ·  Poisoning (14)

Interventions

Atropine (5)  ·  pralidoxime (3)  ·  Albuterol (1)  ·  Biological Control Agents (1)  ·  Fat Emulsions, Intravenous (1)  ·  Organophosphates (1)  ·  Rivastigmine (1)  ·  Rocuronium (1)  ·  Standard of Care (1)  ·  Sugammadex (1)  ·  atropine, pralidoxime iodide, trichlorofon drug combination (1)  ·  lactitol (1)  ·  soybean oil, phospholipid emulsion (1)

Sponsors

Bispebjerg Hospital (2)  ·  Ain Shams University (1)  ·  Amani Hassan Abdel-Wahab (1)  ·  Battelle Memorial Institute (1)  ·  Giriraj Hospital (1)  ·  MicroDose Defense Products L.L.C. (1)  ·  Muhammad Aamir Latif (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Sir Salimullah Medical College Mitford Hospital (1)  ·  Sohag University (1)  ·  Sylhet M.A.G.Osmani Medical College (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University of Edinburgh (1)

Countries

Bangladesh (2)  ·  India (2)  ·  United States (2)  ·  Egypt (1)  ·  Israel (1)  ·  Nepal (1)  ·  Pakistan (1)  ·  Sri Lanka (1)

Top investigators

Anshu Varma (1)  ·  Arif Mahmood, FCPS (1)  ·  Dea H. Kofod, MB (1)  ·  Fazle R Chowdhury, FCPS (1)  ·  Hamdy A. Youssef, Professor (1)  ·  Indika Gawarammana, MD FRCPE PhD (1)  ·  Kirti S Pawar, MBBS,DA (1)  ·  Michael Donahoe, M.D. (1)  ·  Michael Eddleston, MA PhD FRCP (1)  ·  Michael Eddleston, PhD (1)  ·  Paolo DePetrillo, MD (1)  ·  Sana Usman (1)  ·  Timothy Corcoran, Ph.D. (1)  ·  Vajira Weerasinghe, BDS MPhil PhD (1)

Results publications

PMID 17174705, PMID 27464900, PMID 27964728, PMID 30307350